India Pesticides Limited

NSE:IPL.NS

211.53 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 2,203.61,263.21,506.82,019.72,014.351,981.82,176.372,506.612,184.571,703.651,900.331,784.741,702.941,575.551,575.551,669.221,669.221,299.361,299.361,098.7751,098.775
Cost of Revenue 1,534.2825.6709.51,288.81,313.461,090.561,201.951,431.51,097.51,098.92842.65829.43778.53789.86791784.37784.37688.715688.715592.875592.875
Gross Profit 669.4437.6797.3730.9700.89891.24974.421,075.111,087.07604.731,057.68955.31924.41785.69784.55884.85884.85610.645610.645505.9505.9
Gross Profit Ratio 0.3040.3460.5290.3620.3480.450.4480.4290.4980.3550.5570.5350.5430.4990.4980.530.530.470.470.460.46
Reseach & Development Expenses 00000000000002.632.272.452.450.0850.0850.090.09
General & Administrative Expenses 0402.1000361.03000433.1700062.1764.6353.6753.6746.75546.75539.11539.115
Selling & Marketing Expenses 036.800021.3300011.270004.8254.8253.563.562.772.771.931.93
SG&A 429.6438.9357.7358.2379.9382.36418.49458.43444.72444.44367.89343.3301.9666.99569.45557.2357.2349.52549.52541.04541.045
Other Expenses 37.43640.341.332.7830.1345.9123.6432.66-82.8413.3238.537.8600000000
Operating Expenses 429.6438.9505.3498.2508.95500.36539.63577.4554.87158.43467.76425.88389.39374.9373.5394.89394.89315.9315.9312.895312.895
Operating Income 239.8-1.3332.3274224.72421.01480.7521.35564.86427.75602.94567.93572.88404.09404.35480.525480.525263.48263.48181.935181.935
Operating Income Ratio 0.109-0.0010.2210.1360.1120.2120.2210.2080.2590.2510.3170.3180.3360.2560.2570.2880.2880.2030.2030.1660.166
Total Other Income Expenses Net 26.821.4-7.4-8.8-13.41-15.2-17.55-20.06-18.73-28.1-12.43-4.31-116.4456.4458.5058.50521.97521.975-0.545-0.545
Income Before Tax 266.620.1324.9265.2211.31405.81463.15501.29546.13399.65590.51563.62561.88410.535410.795489.03489.03285.455285.455181.39181.39
Income Before Tax Ratio 0.1210.0160.2160.1310.1050.2050.2130.20.250.2350.3110.3160.330.2610.2610.2930.2930.220.220.1650.165
Income Tax Expense 71.89.58570.256.8104.58115.17129.1135.1692.92158.83142.74141.67100.47100.56126.545126.54566.04566.04546.88546.885
Net Income 194.810.6239.9195155.2301.23347.8372.19410.97306.73431.68420.88420.21310.065310.235362.485362.485219.41219.41134.505134.505
Net Income Ratio 0.0880.0080.1590.0970.0770.1520.160.1480.1880.180.2270.2360.2470.1970.1970.2170.2170.1690.1690.1220.122
EPS 1.690.0922.081.691.342.63.023.233.572.663.753.663.762.782.783.253.251.971.971.211.21
EPS Diluted 1.690.0922.081.691.342.63.023.233.562.653.753.663.762.782.783.253.251.971.971.211.21
EBITDA 281.438.3371310.9260.21451.49511.26549.13589.83454.47625.23586.44590.42418.74419496.5496.5276.11276.11194.585194.585
EBITDA Ratio 0.1280.030.2460.1540.1290.2280.2350.2190.270.2670.3290.3290.3470.2660.2660.2970.2970.2120.2120.1770.177